Subscribe to RSS - ExceleraRx


In brief: Invacare sticks to target, Quality Biomedical takes on investor


ELYRIA, Ohio – Invacare reaffirmed its long-term target of $85 million to $105 million adjusted EBITDA run-rate by the fourth quarter of 2020 at the Baird Global Healthcare Conference in New York on Sept. 4.

ExceleraRx launches home infusion solution


MINNEAPOLIS – ExceleraRx has launched Excelera Home Infusion Solutions, a new consulting, project management and revenue cycle management solution that enables health systems to build and manage a home infusion pharmacy.